Vaso-reactivity of isolated bovine intra-mammary artery to endogenous prostanoids and nitric oxide
N. TRAKRANRUNGSIE
Department of Animal Health and Biomedcal Sciences, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
Search for more papers by this authorCorresponding Author
J. A. WILL
Department of Animal Health and Biomedcal Sciences, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
J.A. Will, Department of Animal Health and Biomedical Sciences, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.Search for more papers by this authorN. TRAKRANRUNGSIE
Department of Animal Health and Biomedcal Sciences, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
Search for more papers by this authorCorresponding Author
J. A. WILL
Department of Animal Health and Biomedcal Sciences, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
J.A. Will, Department of Animal Health and Biomedical Sciences, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.Search for more papers by this authorAbstract
The modulatory role of locally produced cyclooxygenase products and endothelium-derived nitric oxide in controlling vascular tone was investigated in bovine intra-mammary artery. Vascular reactivity initiated by vasoactive compounds, endothelin-1 (ET-1), bradykinin (BK), and substance P (SP) was measured isometrically in an isolated tissue bath. The effects of a cyclooxygenase inhibitor, indomethacin (10−5 M) and an inhibitor of nitric oxide production, Nω-Nitro L-Arginine (L-NNA: 3 x 10−4 M) were determined during agonistmediated responses. Indomethacin alone markedly enhanced vascular contraction produced by ET-1, while L-NNA did not. Inhibition of endothelium-derived nitric oxide synthesis by L-NNA, however, significantly attenuated BK-and SP-induced vascular relaxations, whereas indomethacin had slight influence. The potentiation between indomethacin and L-NNA in regulating vasomotor tone was not observed in this vascular bed. Thus, it appeared that both the cyclooxygenase and endothelium-derived nitric oxide pathways participated in modifying vascular reactivity. Domination of one pathway over the other depended upon the agonist used to stimulate vascular tissue.
References
- Arner, M. & Hogestatt, E. D. (1991) Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries. Acta Physiologica Scandinavica, 142, 165–172.
- Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A. & Karin, M. (1995) Immunosuppression by glucocorticoids: Inhibition of NF-kB activity through induction of IkB synthesis. Science, 270, 286–290.
- Bassenge, E. (1992) Endothelial regulation of coronary tone. In Endothelial regulation of vascular tone. Eds U. Ryan & G. M. Rubanyi, pp. 225–264. Marcel Dekker Inc., New York .
- Beasley, D. (1990) Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. American Journal of Physiology, 259, R38–44.
- Berridge, M. J. (1993) Inositol trisphosphate and calcium signalling. Nature, 361, 315–325.
- Berti, F., Rossoni, G., Della Bella, D., Villa, L. M., Buschi, A., Trento, F., Berti M. & Tondo, C. (1993) Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin-1 activity. Journal of Cardiovascular Pharmacology, 22, 321–326.
- Burvenich, C. (1989) New insights in the experimental approach of the physiology and the pathophysiology of the mammary gland. Mastitis seminar, Kalamazoo , USA , March 11-15th, 1989, 26–46. Upjohn Company.
- Conlon, P. D. (1988) Nonsteroidal drugs used in the treatment of inflammation. Veterinary Clinics of North America Small Animal Practice, 18, 1115–1131.
- Cullor, J. S. (1991) Symposium on mastitis in dairy cows. Veterinary Medicine, August, 828–850.
- de Nucci, G., Gryglewski, R. J., Warner, T. D. & Vane, J. R. (1988) Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proceedings of the National Academy of Sciences of the United States of America, 85, 2334–2338.
- DeGraves, F. J. & Anderson, K. L. (1990) Anti-inflammatory therapy for acute coliform mastitis. In Proceedings of the International Symposium of Bovine Mastitis. Indianapolis, pp 261–265.
- DeGraves, F. J. & Anderson, K. L. (1993) Ibuprofen treatment of endotoxin-induced mastitis in cows. American Journal of Veterinary Research, 54, 1128–1135.
- Filep, J. G., Battistini, B., Cote, Y. P., Beaudoin, A. R. & Sirois, P. (1991) Endothelin-1 induces prostacyclin release from bovine aortic endothelial cells. Biochemical & Biophysical Research Communications, 177, 171–176.
- Forstermann, U. (1992) Phospholipid metabolsim and EDRF production. In Endothelial regulation of vascular tone. Eds U. Ryan & G. M. Rubanyi pp. 121–136. Marcel Dekker Inc., New York .
- Furchgott, R. F. & Vanhoutte, P. M. (1989) Endothelium-derived relaxing and contracting factors. The FASEB Journal, 3, 2007–2018.
- Garrison, J. C. (1990) Histamine, bradykinin, 5-hydroxytryptamine, and their antagonists. In Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th edn. Eds A. G. Gilman, T. W. Rall, A. S. Nies & P. Taylor pp. 575–599. Pergamon Press, Oxford .
- Gerros, T. C., Semrad, S. D., Proctor, R. A. & LaBorde, A. (1993) Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves. American Journal of Veterinary Research, 54, 2121–2127.
- Hyslop, S. & de Nucci, G. (1991) The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells. Wiener Klinische Wochenschirft, 103, 422–434.
- Ignarro, L. J., Buga, G. M., Byrns, R. E. & Chaudhuri, G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences of the United States of America, 84, 9265–9269.
- Kilbourn, R. G., Jubran, A., Gross, S. S., Griffith, O. W., Levi R. Adams J. & Lodato, R. F. (1990) Reversal of endotoxin-mediated shock by Ngmethyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochemical & Biophysical Research Communications, 172, 1132–1138.
- Lamas, S., Michel, T., Brenner, B. M. & Marsden, P. A. (1991) Nitric oxide synthesis in endothelial cells: Evidence for a pathway inducible by TNF-alpha. American Journal of Physiology, 261, C634–641.
- Linzell, J. L. (1974) Mammary blood flow and methods of identifying and measuring precursors of milk. In Lactation, Vol. 1. Eds B. L. Larson & V. R. Smith pp. 143–225. Academic Press, New York .
- Luscher, T. F. (1990) Endothelium-derived relaxing and contracting factors. A new concept in hypertension American Journal of Hypertension, 3, 317–330.
-
Marceau, F. &
Tremblay, B. (1989) Prostacyclin release induced by neurokinins in cultured human endothelial cells.
Canadian Journal of Physiology & Pharmacology, 67, 157–162.
10.1139/y89-026 Google Scholar
- Mitchell, J. A., de Nucci, G., Warner, T. D. & Vane, J. R. (1992) Different patterns of release of endothelium-derived relaxing factor and prostacyclin. British Journal of Pharmacology, 105, 485–489.
- Mitchell, J. A., Belvisi, M. G., Akarasereenint, P., Robbins, R. A., Kwon O. J., Croxtall, J., Barnes, P. J. & Vane, J. R. (1994) Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. British Journal of Pharmacology. 113, 1008–1014.
- Moncada, S., Palmer, R. M. & Higgs, E. A. (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacological Reviews, 43, 109–142.
- Noll, G., Buhler, F. R., Yang, Z. & Luscher, T. F. (1991) Different potency of endothelium-derived relaxing factors against thromboxane, endothelin, and potassium chloride in intramyocardial porcine coronary arteries. Journal of Cardiovascular Pharmacology, 18, 120–126.
- Rodenburg, D. A., Chaet, M. S., Bass, A. C., Arkovitz, M. S. & Garcia V. F. (1995) Nitric oxide: an overview. American Journal of Surgery. 170, 292–303.
- Schror, K. (1992) Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. Journal of Cardiovascular Pharmacology, 20 (Suppl. 9), S68–73.
- Southan, G. J. & Szabo, C. (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochemical Pharmacology, 51, 383–394.
- Suzuki, Y., Satoh, S., Ikegaki, I., Asano, T., Shibuya, M., Sugita, K., Lederis, K. & Rorstad, O. (1990) Endothelin causes contraction of canine and bovine arterial smooth muscle in vitro and in vivo. Acta Neurochiruragica Wiener, 104, 42–47.
- Thomas, G., Vargas, R., Wroblewska, B. & Ramwell, P. W. (1989) Role of the endothelium and arginine peptides on the vaso-motor response of porcine internal mammary artery. Life Sciences, 44, 1823–1830.
- Vane, J. R. & Botting, R. M. (1996) Mechanism of action of anti-inflammatory drugs. Scandinavian Journal of Rheumatology, 25 (suppl. 102), 9–12.
- Walsh, D. A., Wharton, J., Blake, D. R. & Polak, J. M. (1992) Neural and endothelial regulatory peptides, their possible involvement in inflammation. International Journal of Tissue Reactions, 14, 101–111.
- Zawadski, J. V., Furchgott, R. F. & Cherry, P. (1981) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by substance P [Abstract]. Federation Proceedings, 40, 689.
- Ziv, F. (1992) Treatment of peracute and acute mastitis. Veterinary Clinics of North America Food Animal Practice, 8, 1–15.